论文部分内容阅读
我院自1986年1月～1987年12月以MeCCNU为主的联合化疗方案治疗晚期胰腺癌7例,获有效率57.2％,现报道如下: 资料和方法 本组共7例。经病理诊断者1例,剖腹探查诊断者2例,经PTCD、B超和CT诊断者3例,仅1例经B超和CT诊断。男:女为5:2。年龄42～76岁。全部病人均为有肝或十二指肠等脏器受侵或转移的晚期病人。联合化疗方案为:MeCCNU100～200mg,口服,第1天;甲氨喋呤20～30mg,
In our hospital from January 1986 to December 1987, a joint chemotherapy regimen based on MeCCNU was used to treat 7 cases of advanced pancreatic cancer with an effective rate of 57.2%. The report is as follows: Data and Methods There were 7 cases in this group. There were 1 case diagnosed by pathology, 2 cases diagnosed by laparotomy, 3 cases diagnosed by PTCD, B-ultrasonography and CT, and only 1 case diagnosed by B-ultrasonography and CT. Male: The female is 5:2. Age 42 to 76 years old. All patients were advanced patients with invasion or metastasis of organs such as the liver or duodenum. Combined chemotherapy regimens: MeCCNU 100 ~ 200mg, oral, the first day; Methotrexate 20 ~ 30mg,